Frameshift mutations in peripheral blood as a biomarker for surveillance of Lynch syndrome. Song Y, Loomans-Kropp H, Baugher RN, Somerville B, et al. J Natl Cancer Inst 2024;116:957-965.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Song Y, Loomans-Kropp H, Baugher RN, Somerville B, et al. Frameshift mutations in peripheral blood as a biomarker for surveillance of Lynch syndrome. J Natl Cancer Inst 2024;116:957-965.
PMID: 38466935